Literature DB >> 24936660

Prevalence, phenomenology and comorbidity of body dysmorphic disorder (dysmorphophobia) in a clinical population.

G Perugi1, D Giannotti, F Frare, S D Vaio, E Valori, L Maggi, G B Cassano, H S Akiskal.   

Abstract

Dysmorphophobia (body dysmorphic disorder), defined as a preoccupation with an imaginary or minimal defect in appearance, has been known for more than a century but has received relatively little empirical study. The authors investigated the demographics, phenomenology, course, associated psychopathology and family history in a series of 58 patients (34 men and 24 women) with the disorder. The patients were assessed with the Hopkins Symptom Checklist and two specially constructed instruments developed by the authors. The mean age at onset of body dysmorphic disorder was 17 (sd = 3.8) years and the average duration was 9 (sd = 5.3) years. The most common preoccupations were defects of the face, nose, genitals and legs. Seventy-nine percent of the patients reported excessive mirror checking and 53% reported attempts to camouflage their 'deformities'. As a result of their symptoms, 89.6% avoided the usual social activities, 51.7% showed an impairment of their academic or job performance, 45% experienced suicidal ideation and 36% showed aggressive behaviour. Seventy-two percent of the patients had an associated lifetime diagnosis of a major mood disorder and 74% of an anxiety disorder. Body dysmorphic disorder has a generally chronic course, causes considerable distress and a serious impairment in many areas, and shows strong links with mood and obsessive-compulsive disorders.

Entities:  

Keywords:  body dysmorphic disorder; clinical features; comorbidity; dysmorphophobia

Year:  1997        PMID: 24936660     DOI: 10.3109/13651509709024707

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  14 in total

Review 1.  Body dysmorphic disorder: some key issues for DSM-V.

Authors:  Katharine A Phillips; Sabine Wilhelm; Lorrin M Koran; Elizabeth R Didie; Brian A Fallon; Jamie Feusner; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

2.  Body dysmorphic disorder: recognizing and treating imagined ugliness.

Authors:  Katharine A Phillips
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

Review 3.  Cognitive-behavioral therapy for youth with body dysmorphic disorder: current status and future directions.

Authors:  Katharine A Phillips; Jamison Rogers
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2011-04

Review 4.  [Suicide risk in somatoform disorders].

Authors:  Giancarlo Giupponi; Ignazio Maniscalco; Sandra Mathà; Carlotta Ficco; Georg Pernther; Livia Sanna; Maurizio Pompili; Hans-Peter Kapfhammer; Andreas Conca
Journal:  Neuropsychiatr       Date:  2017-09-22

5.  Modular cognitive-behavioral therapy for body dysmorphic disorder.

Authors:  Sabine Wilhelm; Katharine A Phillips; Jeanne M Fama; Jennifer L Greenberg; Gail Steketee
Journal:  Behav Ther       Date:  2011-05-01

6.  The Presentation of Body Dysmorphic Disorder in Medical Settings.

Authors:  Katharine A Phillips
Journal:  Prim psychiatry       Date:  2006-07

7.  Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder.

Authors:  Katharine A Phillips; Jason M Siniscalchi; Susan L McElroy
Journal:  Psychiatr Q       Date:  2004

8.  Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting.

Authors:  Michelle Conroy; William Menard; Kathryn Fleming-Ives; Poonam Modha; Hilary Cerullo; Katharine A Phillips
Journal:  Gen Hosp Psychiatry       Date:  2008 Jan-Feb       Impact factor: 3.238

9.  Body dysmorphic disorder, social anxiety and depressive symptoms in Chinese medical students.

Authors:  Yanhui Liao; Natalie P Knoesen; Yunlong Deng; Jinsong Tang; David J Castle; Riteesh Bookun; Wei Hao; Xiaogang Chen; Tieqiao Liu
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-09-27       Impact factor: 4.328

10.  A prospective pilot study of levetiracetam for body dysmorphic disorder.

Authors:  Katharine A Phillips; William Menard
Journal:  CNS Spectr       Date:  2009-05       Impact factor: 3.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.